Walker v. Saul

CourtDistrict Court, E.D. Missouri
DecidedAugust 2, 2022
Docket4:21-cv-00185
StatusUnknown

This text of Walker v. Saul (Walker v. Saul) is published on Counsel Stack Legal Research, covering District Court, E.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walker v. Saul, (E.D. Mo. 2022).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION

MARTHA WALKER, ) ) Plaintiff, ) ) vs. ) No. 4:21-cv-185-MTS ) KILOLO KIJAKAZI, Acting Commissioner of ) the Social Security Administration, ) ) Defendant. )

MEMORANDUM AND ORDER This matter is before the Court for review of the final decision of Defendant, the Acting Commissioner of Social Security, denying the application of Martha Walker (“Plaintiff”) for Disability Insurance Benefits (“DIB”).1 In September 2018, Plaintiff applied for DIB under Title II of the Social Security Act, 42 U.S.C. §§ 401–434 (the “Act”). Plaintiff alleged disability due to heart attack with stents, stroke with extreme dizziness, mini strokes with anemia and brain lesions, diverticulitis and colitis, back surgery, neck surgery, cardiac spasms, high blood pressure, and asthma. (Tr. 194). In July 2020, following a hearing, an Administrative Law Judge (“ALJ”) issued his decision finding that Plaintiff was not disabled as defined in the Act. (Tr. 10–21). For the following reasons, the Court affirms. I. Evidence before the ALJ A. Overview of Relevant Facts and Medical History Although Plaintiff’s medical records show several health impairments, the Court will discuss just those pertinent to its analysis in this Memorandum and Order. As pertinent here,

1 Section 1383(c)(3) of the Act provides for judicial review of the SSA Commissioner’s “final decision.” After the ALJ concluded Plaintiff was not disabled under the Act, (Tr. 10–21), the Appeals Council denied Plaintiff’s request for review, (Tr. 1–4); thus, the ALJ’s decision stands as the Commissioner’s final decision. Plaintiff alleges disability, with an alleged onset date of October 28, 2017, due to a history of strokes and heart attacks and its effects of fatigue, dizziness, and difficulty handling stress. Prior to her alleged onset date of disability, Plaintiff underwent angioplasty of the first major coronary artery in 1996 with stenting in 1998 and 2016. (Tr. 829–30). Plaintiff has a history

of coronary stent placement and cerebral vascular accidents (strokes) with “no residual deficits.” (Tr. 452). In February 2017, Plaintiff’s cardiologist, Dr. Christopher Speidel, noted Plaintiff’s chest pain symptoms were often precipitated by emotional stress. (Tr. 817–18). In May 2017, Plaintiff saw Dr. John McGarry for generalized weakness on her right side after allegedly experiencing nausea, chest pain, and loss of fine motor skills. (Tr. 312). Dr. McGarry diagnosed Plaintiff with orthostatic hypotension, dizziness, and giddiness and advised her to go to the emergency room (“ER”). (Tr. 314). There, Plaintiff experienced transient neurological events but exhibited normal sensation, reflexes, gait, and a neurological examination; aside from elevated blood pressure, her overall workup was negative. (Tr. 310, 309, 323–24, 458, 461, 465, 408). In June 2017, Dr. Ashutosh Patel, Plaintiff’s physician, did not place any limitations on her

ability to work. (Tr. 1294). Electrodiagnostic testing performed showed mild median and ulnar nerve entrapment involving the sensory fibers. (Tr. 630). There were no signs of myopathy. In July 2017, Dr. Patel completed a form stating that Plaintiff did not have any cognitive deficits that would prevent her from returning to work. (Tr. 1293–94, 1835). In August 2017, Plaintiff reported to Dr. Patel that she was experiencing fatigue, weakness, increased dizziness, trouble concentrating, and that her job as a financial consultant was “very stressful.” (Tr. 1127). On September 1, 2017, Dr. Patel released her for return to work. (Tr. 1291). Plaintiff stated that she felt better in September 2017. (Tr. 1123). In October 2017, the month Plaintiff alleged disablement, she saw Dr. Tariq Alam for continued muscle weakness, fatigue, and intermittent blurred vision. (Tr. 622). Dr. Alam noted that Plaintiff’s alleged fatigue and weakness were “stable” and comprehensive workups for neuromuscular disorders were negative. Plaintiff’s neurological examination was normal, and she

continued to demonstrate full muscle strength in all four extremities and a normal gait. (Tr. 625). That month, she also reported that she may change jobs because her work was too stressful but that her dizziness was improving. (Tr. 1119). In January 2018, Plaintiff reported fatigue for “many months,” and Dr. Bhaskara Gadi subsequently diagnosed Plaintiff with chronic anemia.2 (Tr. 1015). In May 2018, Plaintiff saw Dr. Jeffrey Calvin for episodes of weakness, stating that the episodes had worsened over the previous two to five years. (Tr. 641–42). Plaintiff also reported episodes of dizziness and blurred vision that lasted up to a few hours, three times per week.3 She reported periodic coronary vasospasms and episodes of generalized weakness triggered by physical activity, such as yardwork. She stated that her weakness episodes also resolved once she got a good night of sleep.

Plaintiff’s neurological examination was normal, and she continued to demonstrate a normal gait and full muscle strength in her upper and lower extremities. Plaintiff was diagnosed with episodic muscle weakness, ataxia, and vertigo and it was recommended that she follow up with an ear, nose, and throat specialist. (Tr. 644, 652, 674). In November 2018, Plaintiff visited the ER for chest pain, but her workup was negative during a two-day hospitalization. (Tr. 752, 755). There, Dr. Rachel Brown diagnosed her with unspecified chest pain and near syncope based on her report that she felt like she might pass out.

2 In September 2018, Plaintiff’s diagnosis changed to normocytic anemia and neutropenia. (Tr. 1029). 3 Though Plaintiff had been complaining of intermittent blurring of her vision, it was noted in October 2018 that her vision was correctable to 20/25 and 20/30. (Tr. 742). The notes state that her prescription was updated, and she was advised to return in one year. (Tr. id.). (Tr. 757). It is noted that Plaintiff reported being under a lot of stress and had a history of coronary vasospasms. (Tr. 759). Dr. Patel diagnosed Plaintiff with chest pain, hypertension, coronary artery spasm, chronic pain, reflux disease, hyperlipidemia, and major depression. (Tr. 766). Dr. Azamuddin Khaja also diagnosed Plaintiff with coronary artery disease with possible Prinzmetal

angina. (Tr. 771). Imaging of her chest was negative as well as her cardiac workup; Plaintiff’s symptoms were attributed to hypotension triggered by her nitroglycerin. (Tr. 764, 771, 776, 781). Her hypertension, chronic pain, and gastroesophageal reflux disease (“GERD”) were noted to be stable and well-controlled with medication. (Tr. 766). In January 2019, Plaintiff’s angina was stable, her lungs clear, and she denied any chest pain. (Tr. 1094, 1097–98). In February 2019, Plaintiff was noted to have normal range of motion in her spine. (Tr. 1897). In March 2019, Plaintiff denied any joint or muscle pains. (Tr. 1195). Her physical and mental status examinations were unremarkable. Her lungs were clear, her heart rhythm was regular, and her gait was normal. In April 2019, she reported her “legs hurt all the time and [are] worse when sitting.” (Tr. 1236). Dr. Khaja diagnosed Plaintiff with atherosclerosis

of native arteries of extremities with intermittent claudication in her bilateral legs. (Tr. 1237). That month, Plaintiff denied dizziness. (Tr. 1892). In July 2019, Plaintiff visited the ER complaining of chest pain, but her cardiac workup remained negative. (Tr. 1379, 1384–85). Dr. Souheil Khoukaz noted that Plaintiff’s New York Heart Association (“NYHA”) classification was “II,” indicating minimal functional restrictions.4 (Tr. 1542). Plaintiff’s loop recorder had not shown signs of arrhythmia, and she had not had any transient ischemic attacks (“TIA”) since 2017. (Tr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Halverson v. Astrue
600 F.3d 922 (Eighth Circuit, 2010)
Hurd v. Astrue
621 F.3d 734 (Eighth Circuit, 2010)
Partee v. Astrue
638 F.3d 860 (Eighth Circuit, 2011)
Michael James Kamann v. Carolyn W. Colvin
721 F.3d 945 (Eighth Circuit, 2013)
Blakeman v. Astrue
509 F.3d 878 (Eighth Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Walker v. Saul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/walker-v-saul-moed-2022.